Base Pharmacy (india)

Base Pharmacy (India) Private Limited, established on July 14, 2021, is a private limited company headquartered in Vadodara, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U51909GJ2021PTC124110. Its authorized and paid-up capital stands at ₹100,000 each. The registered office is located at 403, Pavanveer Plaza, Opp. Indian Oil Petrol Pump, Sama Savli Road, Vadodara, Gujarat, 390008.

The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its product portfolio spans various therapeutic categories such as antibiotics, anti-infectives, anti-inflammatory, anti-arthritic, cardiovascular, anti-diabetics, anti-malarial, cough and cold remedies, multi-vitamins and minerals, anxiolytics, antihistamines, analgesics, antacids, anti-flatulent, erectile dysfunction, veterinary drugs, herbal medicine, and herbal cosmetics.

As of the latest available data, the company has a workforce of zero employees, indicating that it may operate with a lean structure or rely on contract manufacturing partners.

Base Pharmacy (India) Private Limited operates a manufacturing facility located near Vadodara, Gujarat. The facility is WHO-GMP certified, adhering to international standards for Good Manufacturing Practices. It is equipped to produce a wide range of pharmaceutical products, including tablets, capsules, syrups, and injections. The plant's capacity and specific specializations are not publicly disclosed.

The company's leadership comprises two directors:

• Nimeshbhai Ranchhodbhai Patel: Appointed as a director on July 14, 2021.

• Hetal Nimesh Patel: Also appointed as a director on July 14, 2021.

Detailed information regarding other key executives, such as the CEO, CFO, and their specific roles, is not publicly available.

Base Pharmacy (India) Private Limited's export activities are primarily focused on emerging markets in Africa and Southeast Asia. The company has a significant presence in countries such as Ghana, Nigeria, Kenya, Liberia, Cambodia, Myanmar, Laos, and the Philippines. While the company emphasizes its commitment to quality and regulatory compliance, specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly disclosed.

The company's strategic focus on emerging markets in Africa and Southeast Asia aligns with its mission to provide high-quality, affordable medicines to regions with growing healthcare needs. By catering to these markets, Base Pharmacy (India) Private Limited aims to expand its global footprint and contribute to improving healthcare access in these regions. The company's adherence to WHO-GMP standards and its emphasis on quality assurance support its efforts to meet international regulatory requirements and gain market acceptance in these emerging economies.

Base Pharmacy (India) Private Limited's geographic strategy demonstrates a targeted approach to market expansion, focusing on regions with increasing demand for pharmaceutical products. By concentrating its efforts on specific countries in Africa and Southeast Asia, the company aims to build strong market positions and mitigate risks associated with over-diversification. This strategic focus allows for tailored marketing and distribution strategies, fostering deeper market penetration and customer loyalty. However, the company's limited geographic diversification may expose it to regional economic fluctuations and regulatory changes.

Specific information regarding Base Pharmacy (India) Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's export activities are primarily directed towards emerging markets in Africa and Southeast Asia, and it is unclear whether it has pursued approvals for the U.S. market.

The company's manufacturing facility is WHO-GMP certified, indicating compliance with international standards for Good Manufacturing Practices. This certification underscores the company's commitment to producing high-quality pharmaceutical products. However, there is no publicly available information regarding EU GMP certification or EDQM status.

Base Pharmacy (India) Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organization (CDSCO), the national regulatory authority in India. The company's registered office is located in Vadodara, Gujarat, and it is registered under the Corporate Identification Number (CIN) U51909GJ2021PTC124110. Specific details regarding state drug controller approvals and export No Objection Certificates (NOCs) are not publicly disclosed.

As of the latest available information, there are no publicly disclosed records of Form 483 observations, warning letters, or import alerts associated with Base Pharmacy (India) Private Limited. The company's focus on emerging markets in Africa and Southeast Asia suggests that it may not have been subject to regulatory actions from agencies such as the U.S. FDA or the European Medicines Agency.

Base Pharmacy (India) Private Limited operates in a competitive landscape with numerous pharmaceutical manufacturers catering to both domestic and international markets. While specific competitors in overlapping categories are not publicly identified, the company's emphasis on quality, adherence to WHO-GMP standards, and focus on emerging markets position it to compete effectively. The company's product portfolio spans a wide range of therapeutic classes, allowing it to address diverse market needs and differentiate itself from competitors.

Base Pharmacy (India) Private Limited's key differentiators include its commitment to quality, as evidenced by its WHO-GMP certification, and its strategic focus on emerging markets in Africa and Southeast Asia. The company's ability to offer a diverse product portfolio across various therapeutic classes enables it to meet a broad spectrum of healthcare needs. Additionally, the company's emphasis on providing customized solutions and understanding market requirements allows it to build strong relationships with clients and consumers.

Base Pharmacy (India) Private Limited's current strategic direction centers on manufacturing and exporting finished pharmaceutical formulations to emerging markets. The company's adherence to WHO-GMP standards and its focus on quality assurance support its efforts to meet international regulatory requirements and gain market acceptance. Looking ahead, the company may consider expanding its product offerings, exploring new therapeutic areas, and seeking additional regulatory approvals to enhance its global presence and competitiveness.

Base Pharmacy (India) Private Limited demonstrates a commitment to quality and regulatory compliance, as evidenced by its WHO-GMP certification. The company's focus on emerging markets and its diverse product portfolio indicate a proactive approach to market expansion and customer engagement. However, the lack of publicly available information regarding its workforce and specific manufacturing capabilities suggests that potential partners should conduct thorough due diligence to assess the company's operational capacity and reliability.

Importers should verify the following certifications to ensure product quality and regulatory compliance:

• WHO-GMP Certification: Confirm the validity of the WHO-GMP certification to ensure adherence to international manufacturing standards.

• EU GMP Certification: If applicable, verify EU GMP certification to assess compliance with European manufacturing standards.

• FDA Facility Registration: If the company exports to the U.S., confirm FDA facility registration to ensure compliance with U.S. regulations.

• ISO Certifications: Verify any relevant ISO certifications to assess the company's quality management systems.

To verify these certifications, importers should request copies of the certificates directly from the company and cross-reference them with the issuing authorities' databases or official websites.

Importers should undertake the following steps to assess Base Pharmacy (India) Private Limited:

• Request Documentation: Obtain copies of the company's WHO-GMP certification, EU GMP certification (if applicable), FDA facility registration (if applicable), and any relevant ISO certifications.

• Verify Certifications: Cross-reference the provided certifications with the issuing authorities' databases or official websites to confirm their validity.

• Assess Manufacturing Capabilities: Evaluate the company's manufacturing facility, including capacity, equipment, and adherence to quality standards.

• Review Financial Stability: Analyze the company's financial statements to assess its financial health and ability to fulfill orders.

• Check Regulatory Compliance: Ensure the company complies with all relevant regulatory requirements in its target markets.

• Evaluate Product Quality